BioStem Technologies, Inc.
BSEM
$4.04
$0.133.19%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 292.21M | 300.15M | 332.45M | 301.83M | 58.46M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 292.21M | 300.15M | 332.45M | 301.83M | 58.46M |
| Cost of Revenue | 6.28M | 9.31M | 12.37M | 13.75M | 10.86M |
| Gross Profit | 285.94M | 290.84M | 320.08M | 288.08M | 47.60M |
| SG&A Expenses | 263.53M | 262.07M | 284.48M | 254.75M | 25.79M |
| Depreciation & Amortization | 234.80K | 231.20K | 223.40K | 221.30K | 213.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 276.92M | 277.02M | 300.61M | 270.63M | 37.85M |
| Operating Income | 15.29M | 23.14M | 31.84M | 31.20M | 20.61M |
| Income Before Tax | 15.35M | 23.03M | 31.45M | 30.61M | 19.45M |
| Income Tax Expenses | -4.85M | -3.23M | -1.66M | -1.27M | 5.83M |
| Earnings from Continuing Operations | 20.20 | 26.26 | 33.11 | 31.88 | 13.62 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 20.20M | 26.26M | 33.11M | 31.88M | 13.62M |
| EBIT | 15.29M | 23.14M | 31.84M | 31.20M | 20.61M |
| EBITDA | 6.98M | 14.82M | 23.52M | 22.88M | 20.83M |
| EPS Basic | 1.22 | 1.59 | 2.01 | 1.94 | 0.82 |
| Normalized Basic EPS | 0.26 | 0.56 | 0.88 | 0.85 | 0.77 |
| EPS Diluted | 0.80 | 1.09 | 1.41 | 1.41 | 0.60 |
| Normalized Diluted EPS | 0.17 | 0.40 | 0.64 | 0.66 | 0.58 |
| Average Basic Shares Outstanding | 66.67M | 66.24M | 65.83M | 65.47M | 64.14M |
| Average Diluted Shares Outstanding | 90.68M | 88.58M | 93.73M | 86.79M | 77.51M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |